<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01743742</url>
  </required_header>
  <id_info>
    <org_study_id>Antioxidants in Birth Asphyxia</org_study_id>
    <nct_id>NCT01743742</nct_id>
  </id_info>
  <brief_title>First-day High Dose Vitamin C, E in Severe Birth Asphyxia</brief_title>
  <acronym>CEBA</acronym>
  <official_title>The First-day High Dose Vitamin E and Vitamin C in Hypoxic Ischemic Encephalopathy (Following Birth Asphyxia) in Newborns</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sir Takhtasinhji General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sir Takhtasinhji General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study the role of first-day high dose oral vitamin C and first-day single high dose oral
      vitamin E in hypoxic-ischemic encephalopathy in newborns, in the reduction of morbidity and
      adverse neurodevelopmental sequelae.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design: A prospective, randomized controlled trial over 5 months. Patients: Newborns admitted
      within 6 hours after birth with gestation &gt;32 weeks, Apgar score of &lt;6 at 5 minutes, features
      suggestive of neonatal encephalopathy.

      Intervention: After randomization, Group A newborns received oral vitamin C 250 mg once a day
      within a 24-hour interval along with a single dose of vitamin E 200 IU. Group B newborns
      received no intervention.

      Outcome measures: Severity and progression of birth asphyxia, duration of hospitalization and
      mechanical ventilation, mortality, and neurodevelopmental outcome.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2013</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the role of first day high-dose vitamin E and vitamin C in reduction of adverse neurodevelopmental sequel in newborns with birth asphyxia.</measure>
    <time_frame>6 months</time_frame>
    <description>Vitamin C and E were initiated orally within 6 hours of birth.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality and morbidity in newborns with birth asphyxia administered vitamin E and vitamin C.</measure>
    <time_frame>From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 15 DAYS.</time_frame>
    <description>Deaths and Sequel were measured.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Role of single high dose vitamin E and vitamin C in progression or resolution of Hypoxic ischemic encephalopathy.</measure>
    <time_frame>at 12 hours</time_frame>
    <description>progression of birth asphyxia in terms of HIE Sarnat grading.</description>
  </other_outcome>
  <other_outcome>
    <measure>Role of single high dose vitamin E and vitamin C in progression or resolution of Hypoxic-ischemic encephalopathy.</measure>
    <time_frame>15 days</time_frame>
    <description>Grading of HIE and discharge or death and sequel at followup.</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">95</enrollment>
  <condition>Birth Asphyxia</condition>
  <arm_group>
    <arm_group_label>Oral vitamin E, vitamin C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single dose of vitamin E drops 200 IU within 6 hours of birth and vitamin C tablet 250 mg in pulverised form (2 doses at 24 hr interval) via infant feeding tube</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin E, Vitamin C</intervention_name>
    <arm_group_label>Oral vitamin E, vitamin C</arm_group_label>
    <other_name>Evion drops</other_name>
    <other_name>Tablet Limcee</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          1. Apgar score of &lt;6 at 5 minutes

          2. Clinical features suggestive of neonatal encephalopathy (coma, seizures or hypotonia)

        Exclusion Criteria

          1. Newborn hospitalized in neonatal intensive care unit (NICU) after 6 hours of birth

          2. Gestational age &lt;32 weeks.

          3. Lethal congenital anomaly
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jayendra R Gohil, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor Pediatrics, Govt Medical College, Bhavnagar, Gujarat, India</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NICU, Sir T Hospital, Bhavnagar</name>
      <address>
        <city>Bhavnagar</city>
        <state>Gujarat</state>
        <zip>364002</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <results_reference>
    <citation>Darlow BA, Buss H, McGill F, Fletcher L, Graham P, Winterbourn CC. Vitamin C supplementation in very preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2005 Mar;90(2):F117-22.</citation>
    <PMID>15724034</PMID>
  </results_reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>November 29, 2012</study_first_submitted>
  <study_first_submitted_qc>December 4, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2012</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sir Takhtasinhji General Hospital</investigator_affiliation>
    <investigator_full_name>Jayendra R. Gohil, MD, PROF.</investigator_full_name>
    <investigator_title>Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>Oral vitamin C and Oral vitamin E</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asphyxia Neonatorum</mesh_term>
    <mesh_term>Asphyxia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Vitamin E</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

